Sagar Lonial, MD from Emory University Winship Cancer Institute, Atlanta, GA gives a brief overview of the next challenge that lies ahead for multiple myeloma research in the next two years. He describes the need to design new trials that make use of the new tools that have been developed in order to increase the fraction of patients that can be cured.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL.

Visit our website | [ Ссылка ]
Follow on Twitter | [ Ссылка ]
Like on Facebook | [ Ссылка ]

свернуть